The influence of insulin pump treatment on metabolic syndrome parameters in type 2 diabetes mellitus

Wiener klinische Wochenschrift
Zdenek JankovecZdenek Rusavy


The aim of our study was to evaluate the influence of long-term insulin pump treatment (CSII) on the parameters of metabolic syndrome in insulin-resistant patients with poorly controlled type 2 diabetes mellitus. Thirteen obese (BMI>30) patients (8 women, 5 men), average age 58.8+/-9.06 years, treated with an intensified insulin regimen with high doses of insulin (>0.8 IU/kg per 24 h) for at least 12 months were enrolled in the study. Prior to CSII treatment, all patients were reeducated regarding diabetes treatment and metabolic syndrome, and glycemic control parameters were assessed. Insulin resistance was evaluated with the hyperinsulinemic euglycemic clamp test. All tests were repeated after six months of CSII treatment. The Wilcoxon matched-pairs signed-rank test and Spearman's rank correlation coefficient were used for statistical evaluation. Results are presented as median (1st quartile; 3rd quartile). There were no changes in long-term glycemic control during the course of CSII treatment: HbA1c prior to CSII 9.60 (8.95; 10.60) vs. after 6 months 9.80 (9.50; 10.20) %, BMI 33.0 (32.1; 34.2) vs. 32.9 (32.0; 34.5), total daily insulin dose 69.0 (65.0; 94.0) vs. 68.0 (58.9; 92.4) IU/24 h in observed patients. There was a sta...Continue Reading


Apr 28, 2004·Diabetes Care·Edmond A RyanClarissa Wallace
Jul 20, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·J WainsteinI Harman-Boehm


Aug 21, 2013·Journal of the American College of Cardiology·Dimitris TousoulisChristodoulos Stefanadis
Jun 2, 2020·Journal of Diabetes Science and Technology·Guido FreckmannLutz Heinemann

Related Concepts

Diabetes Mellitus, Non-Insulin-Dependent
Endothelium, Vascular
Hb A1a-2
Hypoglycemic Effect
Implantable Programmable Insulin Pump
Insulin Sensitivity
Body Mass Index Procedure
Spearman Rank Correlation Coefficient
Metabolic Syndrome X

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.